Company intelligence / Profile preview

Orphan Medical

Ownership: Private
Development stage: Other

Overview

Orphan Medical was a company focused on producing drugs for rare diseases. It was founded in the 1980s as a direct result of the US Orphan Drug Act of 1983[2][6].

Therapeutic areas: Rare Diseases
Modalities: Small molecules (inferred)
Industry: Biotech

Beyond the preview

Go deeper on Orphan Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orphan Medical.